Search Results - james+hodge

1 Results

Sort By:

Combination Cancer Therapy with HDAC Inhibitors

Abstract: The clinical promise of cancer immunotherapy relies on the premise that the immune system can recognize and eliminate tumor cells identified as non-self. The success of cancer immunotherapy is limited by tumor immune evasion, preventing long-lasting tumor control. Recent evidence suggests that certain anticancer therapies can alter the biology...

Published: 4/8/2024 | Inventor(s): James Hodge, Sofia Gameiro

Keywords(s): Combination Therapy, CTL, HDAC inhibition, Immunotherapy

Category(s): Application > Therapeutics, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Oncology